Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home
Share
Compartir

Publications and Reports

CDC’s CKD Initiative


CKD Factsheet
Chronic Kidney Disease Initiative—Protecting Kidney Health [PDF–420KB]


Albright A, Burrows NR, Jordan R, Williams DE. The Kidney Disease Initiative and the Division of Diabetes Translation at the Centers for Disease Control and Prevention. Am J Kidney Dis. 2009;53(3 Suppl 3):S121–5.

Narva AS, Briggs M, Jordan R, Pavkov ME, Burrows NR, Williams DE. Toward a more collaborative federal response to chronic kidney disease. [PDF–407KB] Adv Chronic Kidney Dis. 2010;17(3):282−288.

Top of Page

Principles and Data Sources for CKD Surveillance


Schoolwerth AC, Engelgau MM, Hostetter TH, Rufo KH, Chianchiano D, McClellan WM, Warnock DG, Vinicor F. Chronic kidney disease: a public health problem that needs a public health action plan. [PDF–191KB] Prev Chronic Dis. 2006;3(2):A57.

Levey AS, Schoolwerth, AC, Burrows NR, Williams DE, Stith KR, McClellan W. Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention. [PDF–432KB] Am J Kidney Dis. 2009;53(3):522−535.

Powe NR, Plantinga L, Saran R. Public health surveillance of CKD: principles, steps, and challenges. [PDF–357KB] Am J Kidney Dis. 2009;53(3 Suppl 3):S37−S45.

Saran R, Hedgeman E, Plantinga L, Burrows NR, Gillespie BW, Young EW, Coresh J, Pavkov M, Williams D, Powe NR; for the CKD Surveillance Team. Establishing a national chronic kidney disease surveillance system for the United States. [PDF-110KB] Clin J Am Soc Nephrol. 2010;5(1):152−161.

Grams ME, Plantinga LC, Hedgeman E, Saran R, Myers GL, Williams DE, Powe NR; CDC CKD Surveillance Team. Validation of CKD and related conditions in existing data sets: A systematic review. [PDF–363KB] Am J Kidney Dis. 2011;57(1):44–54. Epub 2010 Aug 6. Review.

Top of Page

Natural history of CKD


O'Hare AM, Batten A, Burrows NR, Pavkov ME, Taylor L, Gupta I, Todd-Stenberg J, Maynard C, Rodriguez RA, Murtagh FE, Larson EB, Williams DE. Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis. Am J Kidney Dis. 2012 Apr;59(4):513–22.

O'Hare AM, Hailpern SM, Pavkov ME, Rios-Burrows N, Gupta I, Maynard C, Todd-Stenberg J, Rodriguez RA, Hemmelgarn BR, Saran R, Williams DE. Prognostic implications of the urinary albumin to creatinine ratio in veterans of different ages with diabetes. Arch Intern Med. 2010;170(11):930−936.

Top of Page

Screening for CKD


Saydah SH, Pavkov ME, Zhang C, Lacher DA, Eberhardt MS, Burrows NR, Narva AS, Eggers PW, Williams DE. Albuminuria prevalence in first morning void compared with previous random urine from adults in the National Health and Nutrition Examination Survey, 2009–2010. Clin Chem. 2013;59(4):1–9.

Vassalotti JA, Fox CH, Becker BN. Risk factors and screening for chronic kidney disease. Adv Chronic Kidney Dis. 2010;17(3):237–45.

Collins AJ, Vassalotti JA, Wang C, Li S, Gilbertson DT, Liu J, Foley RN, Chen SC, Arneson TJ. Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease. Am J Kidney Dis. 2009;53(3 Suppl 3):S71–7.

Top of Page

Prevalence of CKD


Shahinian VB, Hedgeman E, Gillespie BW, Young EW, Robinson B, Hsu CY, Plantinga LC, Burrows NR, Eggers P, Saydah S, Powe NR, Saran R. Estimating prevalence of CKD stages 3–5 using health system data. Am J Kidney Dis. 2013;61(6):930–938.

Plantinga LC, Crews DC, Coresh J, Miller ER III, Saran R, Yee J, Hedgeman E, Pavkov M, Eberhardt MS, Williams DE, Powe NR; CDC CKD Surveillance Team. Prevalence of chronic kidney disease in U.S. adults with undiagnosed diabetes or prediabetes. Clin J Am Soc Nephrol. 2010;5(4):673−682.

Crews DC, Plantinga LC, Miller ER III, Saran R, Hedgeman E, Saydah SH, Williams DE, Powe NR; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team. Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States. [PDF–466KB] Hypertension. 2010;55(5):1102−1109.

Top of Page

Awareness of CKD


Tuot DS, Plantinga LC, Hsu CY, Jordan R, Burrows NR, Hedgeman E, Yee J, Saran R, Powe NR; Centers for Disease Control Chronic Kidney Disease Surveillance Team. Chronic kidney disease awareness among individuals with clinical markers of kidney dysfunction. [PDF–202KB] Clin J Am Soc Nephrol. 2011;6(8):1838–44.

Plantinga LC, Tuot DS, Powe NR. Awareness of chronic kidney disease among patients and providers. [PDF-226KB] Adv Chronic Kidney Dis. 2010;17(3):225–36.

Plantinga LC, Boulware LE, Coresh J, Stevens LA, Miller ER 3rd, Saran R, Messer KL, Levey AS, Powe NR. Patient awareness of chronic kidney disease: trends and predictors. [PDF–986KB] Arch Intern Med. 2008;168(20):2268–2275.

Top of Page

CKD complications and risk factors

Crews DC, Kuczmarski MF, Grubbs V, Hedgeman E, Shahinian VB, Evans MK, et al. Effect of food insecurity on chronic kidney disease in lower-income Americans. Am J Nephrol. 2014;39(1):27–35.

Grubbs V, Plantinga LC, Tuot DS, Hedgeman E, Saran R, Saydah S, Rolka D, Powe NR; Centers for Disease Control and Prevention CKD Surveillance Team. Americans' use of dietary supplements that are potentially harmful in CKD. Am J Kidney Dis. 2013 May;61(5):739–47.

Plantinga L, Grubbs V, Sarkar U, Hsu CY, Hedgeman E, Robinson B, Saran R, Geiss L, Burrows NR, Eberhardt M, Powe N; CDC CKD Surveillance Team. Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in the United States. [PDF-333KB] Ann Fam Med. 2011;9(5):423–30.

Plantinga L, Lee K, Inker LA, Saran R, Yee J, Gillespie B, Rolka D, Saydah S, Powe NR; CDC CKD Surveillance Team. Association of sleep-related problems with CKD in the United States, 2005–2008. Am J Kidney Dis. 2011;58(4):554–64.

Grubbs V, Plantinga LC, Crews DC, Bibbins-Domingo K, Saran R, Heung M, Patel PR, Burrows NR, Ernst KL, Powe NR; Centers for Disease Control and Prevention CKD Surveillance Team. Vulnerable populations and the association between periodontal and chronic kidney disease. [PDF–232KB] Clin J Am Soc Nephrol. 2011;6(4):711–7. Epub 2011 Feb 24.

Plantinga LC, Johansen K, Crews DC, Shahinian VB, Robinson BM, Saran R, Burrows NR, Williams DE, Powe NR; CDC CKD Surveillance Team. Association of CKD with disability in the United States. [PDF–597KB] Am J Kidney Dis. 2011;57(2):212–27.

Plantinga LC, Miller ER III, Stevens LA, Saran R, Messer K, Flowers N, Geiss L, Powe NR; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team. Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999–2006.[PDF-375KB] Hypertension. 2009;54(1):47–56.

Top of Page

Cost-effectiveness of CKD interventions


Hoerger TJ, Wittenborn J, Zhuo X, Pavkov ME, Burrows NR, Eggers P, Jordan R, Saydah S, Williams DE. Cost-Effectiveness of Screening for Microalbuminuria among African Americans. J Am Soc Nephrol. 2012;23(12):2035–41.

Hoerger TJ, Wittenborn JS, Segel JE, Burrows NR, Imai K, Eggers P, Pavkov ME, Jordan R, Hailpern SM, Schoolwerth AC, Williams DE; Centers for Disease Control and Prevention CKD Initiative. A health policy model of CKD: 1. model construction, assumptions, and validation of health consequences. Am J Kidney Dis. 2010;55(3):452–62.

Hoerger TJ, Wittenborn JS, Segel JE, Burrows NR, Imai K, Eggers P, Pavkov ME, Jordan R, Hailpern SM, Schoolwerth AC, Williams DE; Centers for Disease Control and Prevention CKD Initiative. A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening. Am J Kidney Dis. 2010;55(3):463–73.

Top of Page

Morbidity and Mortality Weekly Reports (MMWRs)


Incidence of ESRD

Trends in Incidence of End-Stage Renal Disease Among Persons With Diagnosed Diabetes — Puerto Rico, 1996–2010

Incidence of End-Stage Renal Disease Attributed to Diabetes Among Persons With Diagnosed Diabetes—United States and Puerto Rico, 1996–2007

Incidence of End-Stage Renal Disease Among Persons with Diabetes—United States, 1990–2002

Racial Differences in Trends of End-Stage Renal Disease, by Primary Diagnosis—United States, 1994–2004


Prevalence of CKD and ESRD

Prevalence of Chronic Kidney Disease and Associated Risk Factors United States, 1999–2004

State-Specific Trends in Chronic Kidney Failure—United States, 1990–2001


Hospitalization and Mortality

Hospitalization Discharge Diagnoses for Kidney Disease—United States, 1980–2005

Kidney Disease Mortality—Michigan, 1989–2005


Dialysis

Reducing Bloodstream Infections in an Outpatient Hemodialysis Center — New Jersey, 2008–2011

Vital Signs: Central Line–Associated Blood Stream Infections—United States, 2001, 2008, and 2009

Hepatitis C Virus Transmission at an Outpatient Hemodialysis Unit—New York, 2001–2008

Infection Control Requirements for Dialysis Facilities and Clarification Regarding Guidance on Parenteral Medication Vials

Elevated Serum Aluminum Levels in Hemodialysis Patients Associated with Use of Electric Pumps—Wyoming, 2007

Acute Allergic-Type Reactions Among Patients Undergoing Hemodialysis—Multiple States, 2007–2008

Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Dialysis Patients—United States, 2005

Nephrogenic Fibrosing Dermopathy Associated with Exposure to Gadolinium-Containing Contrast Agents—St. Louis, Missouri, 2002–2006

Top of Page

 

 
Protect your Kidneys
Send a Kidney Health-e-Card
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC-INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO